Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment.

Shun KanekoKaoru TsuchiyaYutaka YasuiYuki TanakaKento InadaShun IshidoSakura KirinoKoji YamashitaYuka HayakawaTsubasa NobusawaHiroaki MatsumotoTatsuya KakegawaMayu HiguchiKenta TakauraShohei TanakaChiaki MaeyashikiNobuharu TamakiYuka TakahashiHiroyuki NakanishiTakumi IrieShun-Ichi AriizumiMasayuki KurosakiNamiki Izumi

Published in: JGH open : an open access journal of gastroenterology and hepatology (2022)

The patients who underwent CS after TKI therapy for HCC experienced long survival, were relatively young, and exhibited radiologic response to TKIs, and their liver function was either maintained or improved. Therefore, CS may lead to a better prognosis in patients with advanced HCC.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
tyrosine kinase
coronary artery bypass
advanced non small cell lung cancer
middle aged
acute coronary syndrome
combination therapy
epidermal growth factor receptor
patient reported